Large genetic study links telomere-related polygenic risk to distinct idiopathic pulmonary fibrosis subgroups, improving ...
Angiotensin-converting enzyme (ACE) inhibitors were found to be independently associated with reducing all-cause mortality in ...
Background Antifibrotic (AF) therapy has been shown to potentially reduce the risk of lung cancer (LC) in patients with ...
The ATS/ERS 2025 statement on interstitial pneumonia classification updates the 2013 statement, with insights on secondary ...
Gene Expression Data Show Direct Impact on the Core Biology of IPF ...
Despite the development of cutting-edge genetic testing techniques and considerable progress in our understanding of the genetic basis of idiopathic pulmonary fibrosis (IPF), missing heritability and ...
Pulmonary fibrosis significantly impacts sexual function, with 74% of patients experiencing dyspnea during sexual activity, affecting their quality of life. The study used UCSD-SOBQ and SPARC ...
Therapeutic progress for fibrostenotic Crohn’s disease has been stalled in a paradox: Antifibrotic drugs require endpoints ...
In patients with cystic fibrosis, CMTX-101, an immune-enabling antibody therapy, lowered four inflammatory biomarkers and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results